Published in Gut on February 24, 2009
Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One (2010) 6.48
The impact of the gut microbiota on human health: an integrative view. Cell (2012) 6.01
Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A (2013) 5.88
Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut (2012) 3.09
Retracted Gut microbiota is a key modulator of insulin resistance in TLR 2 knockout mice. PLoS Biol (2011) 3.02
Gut microbiome, obesity, and metabolic dysfunction. J Clin Invest (2011) 2.93
High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse. PLoS One (2010) 2.60
Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota. Gut (2011) 2.50
Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes (2011) 2.46
Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat Rev Endocrinol (2011) 2.44
Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol Med (2011) 2.25
Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded? Diabetes Care (2010) 2.22
A high-fat diet is associated with endotoxemia that originates from the gut. Gastroenterology (2012) 2.21
Chronic inflammation in obesity and the metabolic syndrome. Mediators Inflamm (2010) 2.18
Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease. Nutrients (2012) 2.10
Microbial translocation, immune activation, and HIV disease. Trends Microbiol (2012) 2.07
Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes (2012) 1.83
The endocannabinoid system links gut microbiota to adipogenesis. Mol Syst Biol (2010) 1.79
Diet and inflammatory bowel disease: review of patient-targeted recommendations. Clin Gastroenterol Hepatol (2013) 1.75
Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota. Nat Commun (2015) 1.75
The gut microbiota influences blood-brain barrier permeability in mice. Sci Transl Med (2014) 1.73
Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study. BMC Med (2013) 1.71
NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications. Gut Liver (2012) 1.70
Crossover Control Study of the Effect of Personal Care Products Containing Triclosan on the Microbiome. mSphere (2016) 1.69
Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity. ISME J (2014) 1.63
Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice. PLoS One (2012) 1.59
The gut microbiota and its relationship to diet and obesity: new insights. Gut Microbes (2012) 1.52
Intestinal permeability--a new target for disease prevention and therapy. BMC Gastroenterol (2014) 1.52
Variation in the gut microbiota of laboratory mice is related to both genetic and environmental factors. Comp Med (2010) 1.47
Hepatocyte MyD88 affects bile acids, gut microbiota and metabolome contributing to regulate glucose and lipid metabolism. Gut (2016) 1.47
Altered gut microbiota and endocannabinoid system tone in obese and diabetic leptin-resistant mice: impact on apelin regulation in adipose tissue. Front Microbiol (2011) 1.46
Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats. PLoS One (2012) 1.46
Association of Early Exposure of Probiotics and Islet Autoimmunity in the TEDDY Study. JAMA Pediatr (2016) 1.46
Structural resilience of the gut microbiota in adult mice under high-fat dietary perturbations. ISME J (2012) 1.46
Effect of Lactobacillus gasseri BNR17 on Overweight and Obese Adults: A Randomized, Double-Blind Clinical Trial. Korean J Fam Med (2013) 1.43
Retracted Obesity as a consequence of gut bacteria and diet interactions. ISRN Obes (2014) 1.42
Intestinal microbiota could transfer host Gut characteristics from pigs to mice. BMC Microbiol (2016) 1.38
Prebiotic effects of wheat arabinoxylan related to the increase in bifidobacteria, Roseburia and Bacteroides/Prevotella in diet-induced obese mice. PLoS One (2011) 1.37
Inflammation, sanitation, and consternation: loss of contact with coevolved, tolerogenic microorganisms and the pathophysiology and treatment of major depression. Arch Gen Psychiatry (2010) 1.37
Structural modulation of gut microbiota in life-long calorie-restricted mice. Nat Commun (2013) 1.36
Prebiotic fibres dose-dependently increase satiety hormones and alter Bacteroidetes and Firmicutes in lean and obese JCR:LA-cp rats. Br J Nutr (2011) 1.36
Impact of the gut microbiota on the development of obesity and type 2 diabetes mellitus. Front Microbiol (2014) 1.35
Gut microbiota and diabetes: from pathogenesis to therapeutic perspective. Acta Diabetol (2011) 1.30
Ketone body metabolism and cardiovascular disease. Am J Physiol Heart Circ Physiol (2013) 1.29
The gut as a sensory organ. Nat Rev Gastroenterol Hepatol (2013) 1.26
Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion. J Biol Chem (2013) 1.25
Molecular modulation of intestinal epithelial barrier: contribution of microbiota. J Biomed Biotechnol (2010) 1.25
Dietary Polyphenols Promote Growth of the Gut Bacterium Akkermansia muciniphila and Attenuate High-Fat Diet-Induced Metabolic Syndrome. Diabetes (2015) 1.19
Role of intestinal inflammation as an early event in obesity and insulin resistance. Curr Opin Clin Nutr Metab Care (2011) 1.19
Structural modulation of gut microbiota during alleviation of type 2 diabetes with a Chinese herbal formula. ISME J (2014) 1.17
Modulation of the gut microbiota by nutrients with prebiotic properties: consequences for host health in the context of obesity and metabolic syndrome. Microb Cell Fact (2011) 1.16
Is the gut microbiota a new factor contributing to obesity and its metabolic disorders? J Obes (2012) 1.16
Gut microbiota and metabolic syndrome. World J Gastroenterol (2014) 1.14
Role of the normal gut microbiota. World J Gastroenterol (2015) 1.12
Obesity and the gut microbiota: does up-regulating colonic fermentation protect against obesity and metabolic disease? Genes Nutr (2011) 1.10
Gut microbiota: next frontier in understanding human health and development of biotherapeutics. Biologics (2011) 1.08
The Gordian Knot of dysbiosis, obesity and NAFLD. Nat Rev Gastroenterol Hepatol (2013) 1.06
Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders. Front Cell Neurosci (2015) 1.06
Intestinal epithelial MyD88 is a sensor switching host metabolism towards obesity according to nutritional status. Nat Commun (2014) 1.05
Modulation of immunity and inflammatory gene expression in the gut, in inflammatory diseases of the gut and in the liver by probiotics. World J Gastroenterol (2014) 1.05
Akkermansia muciniphila Adheres to Enterocytes and Strengthens the Integrity of the Epithelial Cell Layer. Appl Environ Microbiol (2015) 1.05
High-fat-induced intestinal permeability dysfunction associated with altered fecal bile acids. World J Gastroenterol (2012) 1.04
Restoring specific lactobacilli levels decreases inflammation and muscle atrophy markers in an acute leukemia mouse model. PLoS One (2012) 1.04
Obesity and its associated disease: a role for microbiota? Neurogastroenterol Motil (2012) 1.03
VSL#3 resets insulin signaling and protects against NASH and atherosclerosis in a model of genetic dyslipidemia and intestinal inflammation. PLoS One (2012) 1.02
MicroRNA-21 knockout improve the survival rate in DSS induced fatal colitis through protecting against inflammation and tissue injury. PLoS One (2013) 1.02
Probiotics, prebiotics, and the host microbiome: the science of translation. Ann N Y Acad Sci (2013) 1.01
Wheat-derived arabinoxylan oligosaccharides with prebiotic effect increase satietogenic gut peptides and reduce metabolic endotoxemia in diet-induced obese mice. Nutr Diabetes (2012) 0.99
The role of gut microbiota on insulin resistance. Nutrients (2013) 0.99
The gut microbiome, diet, and links to cardiometabolic and chronic disorders. Nat Rev Nephrol (2015) 0.98
99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: the normal gut microbiota in health and disease. Clin Exp Immunol (2010) 0.98
Modulatory Effects of Gut Microbiota on the Central Nervous System: How Gut Could Play a Role in Neuropsychiatric Health and Diseases. J Neurogastroenterol Motil (2016) 0.97
Diet: friend or foe of enteroendocrine cells--how it interacts with enteroendocrine cells. Adv Nutr (2012) 0.97
Lipopolysaccharides impair insulin gene expression in isolated islets of Langerhans via Toll-Like Receptor-4 and NF-κB signalling. PLoS One (2012) 0.97
Changes in intestinal barrier function and gut microbiota in high-fat diet-fed rats are dynamic and region dependent. Am J Physiol Gastrointest Liver Physiol (2015) 0.97
Gut microbiome and metabolic diseases. Semin Immunopathol (2013) 0.96
Influence of gut microbiota on subclinical inflammation and insulin resistance. Mediators Inflamm (2013) 0.95
Neuropeptides and the microbiota-gut-brain axis. Adv Exp Med Biol (2014) 0.95
Neuropsychiatric comorbidity in obesity: role of inflammatory processes. Front Endocrinol (Lausanne) (2014) 0.95
Probiotics, prebiotics, and synbiotics: gut and beyond. Gastroenterol Res Pract (2012) 0.94
Metabolic endotoxemia with obesity: Is it real and is it relevant? Biochimie (2015) 0.93
Tetrahydro iso-alpha acids from hops improve glucose homeostasis and reduce body weight gain and metabolic endotoxemia in high-fat diet-fed mice. PLoS One (2012) 0.93
Molecular mechanisms and new treatment strategies for non-alcoholic steatohepatitis (NASH). Int J Mol Sci (2014) 0.92
Impact of the gut microbiota on rodent models of human disease. World J Gastroenterol (2014) 0.92
Particulate matter air pollution causes oxidant-mediated increase in gut permeability in mice. Part Fibre Toxicol (2011) 0.92
Endocannabinoids - at the crossroads between the gut microbiota and host metabolism. Nat Rev Endocrinol (2015) 0.92
Adipose tissue NAPE-PLD controls fat mass development by altering the browning process and gut microbiota. Nat Commun (2015) 0.92
Effects of indigestible carbohydrates in barley on glucose metabolism, appetite and voluntary food intake over 16 h in healthy adults. Nutr J (2013) 0.91
Polyphenols and Glycemic Control. Nutrients (2016) 0.91
Gut Microbiota and Metabolic Disorders. Diabetes Metab J (2015) 0.91
Towards microbial fermentation metabolites as markers for health benefits of prebiotics. Nutr Res Rev (2015) 0.91
Gut-liver axis, nutrition, and non-alcoholic fatty liver disease. Clin Biochem (2015) 0.91
How gut microbes talk to organs: The role of endocrine and nervous routes. Mol Metab (2016) 0.91
Dietary metabolites and the gut microbiota: an alternative approach to control inflammatory and autoimmune diseases. Clin Transl Immunology (2016) 0.91
Prebiotic fiber modulation of the gut microbiota improves risk factors for obesity and the metabolic syndrome. Gut Microbes (2012) 0.91
Why is initial bacterial colonization of the intestine important to infants' and children's health? J Pediatr Gastroenterol Nutr (2015) 0.90
Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease. Sci Rep (2015) 0.90
Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A (2005) 33.66
The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A (2004) 26.56
The metabolic syndrome--a new worldwide definition. Lancet (2005) 23.51
TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest (2006) 17.49
Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes (2007) 14.12
Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe (2008) 11.97
Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med (2005) 10.88
Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes (2008) 10.74
Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci U S A (2007) 9.71
Retracted Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes (2007) 5.67
Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia (2007) 5.61
Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol (2006) 3.59
Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling. J Clin Invest (2007) 3.54
Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice. FASEB J (2008) 2.97
Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology (1995) 2.58
Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes. Biochem Biophys Res Commun (2006) 2.56
Molecular physiology and pathophysiology of tight junctions. IV. Regulation of tight junctions by extracellular stimuli: nutrients, cytokines, and immune cells. Am J Physiol Gastrointest Liver Physiol (2000) 2.48
Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc Natl Acad Sci U S A (1996) 2.40
Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon. Gastroenterology (2001) 2.37
Bifidobacterial supplementation reduces the incidence of necrotizing enterocolitis in a neonatal rat model. Gastroenterology (1999) 2.20
C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet. Diabetologia (2007) 2.19
Regulation of airway tight junctions by proinflammatory cytokines. Mol Biol Cell (2002) 2.18
Evaluation of nested PCR-DGGE (denaturing gradient gel electrophoresis) with group-specific 16S rRNA primers for the analysis of bacterial communities from different wastewater treatment plants. FEMS Microbiol Ecol (2002) 2.07
IFN-gamma modulation of epithelial barrier function. Time course, reversibility, and site of cytokine binding. J Immunol (1993) 1.98
The essential role of insulin-like growth factor-1 in the intestinal tropic effects of glucagon-like peptide-2 in mice. Gastroenterology (2006) 1.97
Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor. Diabetes (2006) 1.83
Severity of liver injury in experimental alcoholic liver disease. Correlation with plasma endotoxin, prostaglandin E2, leukotriene B4, and thromboxane B2. Am J Pathol (1993) 1.75
Gut microflora as a target for energy and metabolic homeostasis. Curr Opin Clin Nutr Metab Care (2007) 1.75
Hepatic injury associated with small bowel bacterial overgrowth in rats is prevented by metronidazole and tetracycline. Gastroenterology (1991) 1.72
IL-6 is essential for development of gut barrier dysfunction after hemorrhagic shock and resuscitation in mice. Am J Physiol Gastrointest Liver Physiol (2003) 1.70
Attenuation of obesity-induced adipose tissue inflammation in C3H/HeJ mice carrying a Toll-like receptor 4 mutation. Biochem Biophys Res Commun (2007) 1.63
Hepatic inflammation in rats with experimental small intestinal bacterial overgrowth. Gastroenterology (1990) 1.59
Alcohol causes both tolerance and sensitization of rat Kupffer cells via mechanisms dependent on endotoxin. Gastroenterology (1998) 1.58
Inulin-type fructans modulate gastrointestinal peptides involved in appetite regulation (glucagon-like peptide-1 and ghrelin) in rats. Br J Nutr (2004) 1.55
Intestinal permeability is reduced and IL-10 levels are increased in septic IL-6 knockout mice. Am J Physiol Regul Integr Comp Physiol (2001) 1.55
Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like Peptide-1. Obes Res (2005) 1.50
Kupffer cell sensitization by alcohol involves increased permeability to gut-derived endotoxin. Alcohol Clin Exp Res (2001) 1.44
Intestinal growth-promoting properties of glucagon-like peptide-2 in mice. Am J Physiol (1997) 1.43
Lactobacillus rhamnosus strain GG prevents enterohemorrhagic Escherichia coli O157:H7-induced changes in epithelial barrier function. Infect Immun (2008) 1.43
The prenylflavonoid isoxanthohumol from hops (Humulus lupulus L.) is activated into the potent phytoestrogen 8-prenylnaringenin in vitro and in the human intestine. J Nutr (2006) 1.35
GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet. Am J Physiol Endocrinol Metab (2007) 1.33
Modulation of glucagon-like peptide 1 and energy metabolism by inulin and oligofructose: experimental data. J Nutr (2007) 1.32
Targeted ablation of glucose-dependent insulinotropic polypeptide-producing cells in transgenic mice reduces obesity and insulin resistance induced by a high fat diet. J Biol Chem (2008) 1.31
The role of bifidobacteria in gut barrier function after thermal injury in rats. J Trauma (2006) 1.29
Frontiers in glucagon-like peptide-2: multiple actions, multiple mediators. Am J Physiol Endocrinol Metab (2007) 1.28
Fructans in the diet cause alterations of intestinal mucosal architecture, released mucins and mucosa-associated bifidobacteria in gnotobiotic rats. Br J Nutr (2003) 1.26
Role of endotoxin in the hypermetabolic state after acute ethanol exposure. Am J Physiol (1998) 1.26
Dietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of rats. Br J Nutr (2007) 1.25
Dietary fiber modulates intestinal proglucagon messenger ribonucleic acid and postprandial secretion of glucagon-like peptide-1 and insulin in rats. Endocrinology (1996) 1.22
Involvement of endogenous glucagon-like peptide-1(7-36) amide on glycaemia-lowering effect of oligofructose in streptozotocin-treated rats. J Endocrinol (2005) 1.21
Glucagon-like peptide-2 enhances intestinal epithelial barrier function of both transcellular and paracellular pathways in the mouse. Gut (2000) 1.20
Physiological effects of dietary fructans extracted from Agave tequilana Gto. and Dasylirion spp. Br J Nutr (2007) 1.17
Lactobacillus casei DN-114 001 inhibits the increase in paracellular permeability of enteropathogenic Escherichia coli-infected T84 cells. Res Microbiol (2004) 1.17
Obesity-induced lymphocyte hyperresponsiveness to chemokines: a new mechanism of Fatty liver inflammation in obese mice. Gastroenterology (2008) 1.15
In vivo effects of bifidobacteria and lactoferrin on gut endotoxin concentration and mucosal immunity in Balb/c mice. Dig Dis Sci (2004) 1.13
Chemical gastric inhibitory polypeptide receptor antagonism protects against obesity, insulin resistance, glucose intolerance and associated disturbances in mice fed high-fat and cafeteria diets. Diabetologia (2007) 1.12
Leptin and adipocytokines: bridging the gap between immunity and atherosclerosis. Curr Pharm Des (2007) 1.12
Prebiotic effects of chicory inulin in the simulator of the human intestinal microbial ecosystem. FEMS Microbiol Ecol (2004) 1.08
Relation between colonic proglucagon expression and metabolic response to oligofructose in high fat diet-fed mice. Life Sci (2006) 1.08
Mucosal adaptation to enteral nutrients is dependent on the physiologic actions of glucagon-like peptide-2 in mice. Gastroenterology (2005) 1.06
Risk factors of development of gut-derived bacterial translocation in thermally injured rats. World J Gastroenterol (2004) 1.06
Nutrient-stimulated GLP-2 release and crypt cell proliferation in experimental short bowel syndrome. Am J Physiol Gastrointest Liver Physiol (2004) 1.06
Glucagon-like peptide-2 activates beta-catenin signaling in the mouse intestinal crypt: role of insulin-like growth factor-I. Endocrinology (2007) 1.04
Stress impairs murine intestinal barrier function: improvement by glucagon-like peptide-2. J Pharmacol Exp Ther (2005) 1.04
Role of TNF-alpha in ileum tight junction alteration in mouse model of restraint stress. Am J Physiol Gastrointest Liver Physiol (2008) 1.03
Oxidative stress and septic shock: metabolic aspects of oxygen-derived free radicals generated in the liver during endotoxemia. FEMS Immunol Med Microbiol (2006) 1.02
Supplementation of total parenteral nutrition with butyrate acutely increases structural aspects of intestinal adaptation after an 80% jejunoileal resection in neonatal piglets. JPEN J Parenter Enteral Nutr (2004) 1.00
Insulin-like growth factor I and glucagon-like peptide-2 responses to fasting followed by controlled or ad libitum refeeding in rats. Am J Physiol Regul Integr Comp Physiol (2008) 1.00
Glucagon-like peptide 2 (GLP-2) accelerates the growth of colonic neoplasms in mice. Gut (2004) 1.00
Effects of fermentation products of pro- and prebiotics on trans-epithelial electrical resistance in an in vitro model of the colon. Nutr Cancer (2005) 0.98
Glucagon-like peptide-2-enhanced barrier function reduces pathophysiology in a model of food allergy. Am J Physiol Gastrointest Liver Physiol (2003) 0.96
Intestinal growth adaptation and glucagon-like peptide 2 in rats with ileal--jejunal transposition or small bowel resection. Dig Dis Sci (2001) 0.95
Encapsulated Bifidobacteria reduced bacterial translocation in rats following hemorrhagic shock and resuscitation. Nutrition (2007) 0.93
Inability of Lactobacillus casei strain GG, L. acidophilus, and Bifidobacterium bifidum to degrade intestinal mucus glycoproteins. Scand J Gastroenterol (1995) 0.93
Glucagon-like peptide 2 stimulates intestinal epithelial proliferation in vitro. Dig Dis Sci (2002) 0.92
The truncated metabolite GLP-2 (3-33) interacts with the GLP-2 receptor as a partial agonist. Regul Pept (2002) 0.91
Short-chain fatty acid-supplemented total parenteral nutrition alters intestinal structure, glucose transporter 2 (GLUT2) mRNA and protein, and proglucagon mRNA abundance in normal rats. Am J Clin Nutr (1998) 0.91
Endotoxemia and hepatic injury in a rodent model of hindlimb unloading. J Appl Physiol (1985) (2003) 0.90
Dietary fructans modulate polyamine concentration in the cecum of rats. J Nutr (2000) 0.86
Glucagon-like peptide-2 increases sucrase-isomaltase but not caudal-related homeobox protein-2 gene expression. Am J Physiol Gastrointest Liver Physiol (2000) 0.85
Protective effects of glucagon-like peptide 2 on intestinal ischemia-reperfusion rats. Microsurgery (2008) 0.85
Glicentin inhibits internalization of enteric bacteria by cultured INT-407 enterocytes. Pediatr Surg Int (2007) 0.85
Ethanol exacerbates hepatic microvascular dysfunction, endotoxemia, and lethality in septic mice. Shock (1994) 0.83
Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion. J Cell Biol (2000) 5.71
Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia (2007) 5.61
Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120. Proc Natl Acad Sci U S A (1991) 4.40
Pancreatic beta-cell mass in European subjects with type 2 diabetes. Diabetes Obes Metab (2008) 3.96
Patterns of prehistoric human mobility in polynesia indicated by mtDNA from the Pacific rat. Proc Natl Acad Sci U S A (1998) 2.22
Morphometric analysis of recombinant soluble CD4-mediated release of the envelope glycoprotein gp120 from HIV-1. AIDS Res Hum Retroviruses (1990) 2.13
Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues. Nature (1990) 2.13
Beta-blockers and life expectancy in ischemic heart-disease. Lancet (1972) 1.74
Keutel syndrome: further characterization and review. Am J Med Genet (1998) 1.69
Microevolution and mega-icebergs in the Antarctic. Proc Natl Acad Sci U S A (2005) 1.68
Nuclear DNA sequences detect species limits in ancient moa. Nature (2003) 1.60
Adipokines oversecreted by omental adipose tissue in human obesity. Am J Physiol Endocrinol Metab (2007) 1.48
Role of gut microflora in the development of obesity and insulin resistance following high-fat diet feeding. Pathol Biol (Paris) (2008) 1.47
Acute nutrient regulation of the unfolded protein response and integrated stress response in cultured rat pancreatic islets. Diabetologia (2007) 1.44
Ancient DNA from Polynesian rats: extraction, amplification and sequence from single small bones. Electrophoresis (1997) 1.44
Chronic aristolochic acid toxicity in rabbits: a model of Chinese herbs nephropathy? Kidney Int (2001) 1.43
Azithromycin and the treatment of lymphocytic airway inflammation after lung transplantation. Am J Transplant (2014) 1.43
Lack of selectivity of URB602 for 2-oleoylglycerol compared to anandamide hydrolysis in vitro. Br J Pharmacol (2006) 1.36
Persistent hyperinsulinaemic hypoglycaemia of infancy: a heterogeneous syndrome unrelated to nesidioblastosis. Arch Dis Child Fetal Neonatal Ed (2000) 1.33
Oligofructose promotes satiety in healthy human: a pilot study. Eur J Clin Nutr (2006) 1.30
Inulin-type fructans of longer degree of polymerization exert more pronounced in vitro prebiotic effects. J Appl Microbiol (2007) 1.29
Molecular evolution at subzero temperatures: mitochondrial and nuclear phylogenies of fishes from Antarctica (suborder Notothenioidei), and the evolution of antifreeze glycopeptides. Mol Biol Evol (1994) 1.27
Glucose regulation of islet stress responses and beta-cell failure in type 2 diabetes. Diabetes Obes Metab (2009) 1.26
Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide. Br J Pharmacol (2001) 1.25
Pulse oximetry: evaluation of accuracy during outpatient general anesthesia for oral surgery. Anesth Prog (1988) 1.23
Dietary fructans. Annu Rev Nutr (1998) 1.20
Respiratory syncytial virus glycoproteins. Virology (1983) 1.17
Analogues and homologues of N-palmitoylethanolamide, a putative endogenous CB(2) cannabinoid, as potential ligands for the cannabinoid receptors. Biochim Biophys Acta (1999) 1.14
Heptad-repeat regions of respiratory syncytial virus F1 protein form a six-membered coiled-coil complex. Biochemistry (2000) 1.13
Gene flow on the ice: genetic differentiation among Adélie penguin colonies around Antarctica. Mol Ecol (2001) 1.13
Molecular cloning and sequence analysis of the human parainfluenza 3 virus mRNA encoding the P and C proteins. Virology (1986) 1.12
Ancient DNA and conservation: lessons from the endangered kiwi of New Zealand. Mol Ecol (2008) 1.11
Nucleic acids of respiratory syncytial virus. J Virol (1980) 1.11
Morphological mosaicism of the pancreatic islets: a novel anatomopathological form of persistent hyperinsulinemic hypoglycemia of infancy. J Clin Endocrinol Metab (2011) 1.09
Anticonvulsant and neurotoxicological properties of 4-amino-N-(2-ethylphenyl)benzamide, a potent ameltolide analogue. Biomed Pharmacother (1997) 1.07
Neonatal hyperinsulinemic hypoglycemia: heterogeneity of the syndrome and keys for differential diagnosis. J Clin Endocrinol Metab (1998) 1.07
Molecular cloning and sequence analysis of the human parainfluenza 3 virus RNA encoding the nucleocapsid protein. Virology (1986) 1.06
Inulin and oligofructose modulate lipid metabolism in animals: review of biochemical events and future prospects. Br J Nutr (2002) 1.01
Immediate persistent infection by human parainfluenza virus 3: unique fusion properties of the persistently infected cells. J Gen Virol (1987) 1.00
Wheat-derived arabinoxylan oligosaccharides with prebiotic effect increase satietogenic gut peptides and reduce metabolic endotoxemia in diet-induced obese mice. Nutr Diabetes (2012) 0.99
Induction of adiponectin in skeletal muscle of type 2 diabetic mice: In vivo and in vitro studies. Diabetologia (2006) 0.99
Pancreatic B-cell proliferation in persistent hyperinsulinemic hypoglycemia of infancy: an immunohistochemical study of 18 cases. Mod Pathol (1998) 0.98
Intracellular synthesis of human parainfluenza type 3 virus-specified polypeptides. J Virol (1985) 0.98
Effects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis: results of a pilot study. Eur J Clin Nutr (2005) 0.97
Trimethylaminuria is caused by mutations of the FMO3 gene in a North American cohort. Mol Genet Metab (1999) 0.97
Hydroxyethylene isostere inhibitors of human immunodeficiency virus-1 protease: structure-activity analysis using enzyme kinetics, X-ray crystallography, and infected T-cell assays. Biochemistry (1992) 0.96
Letter: Hypertension and myocardial infarction. Br Med J (1974) 0.96
Haeme-oxygenase 1 expression in rat pancreatic beta cells is stimulated by supraphysiological glucose concentrations and by cyclic AMP. Diabetologia (2003) 0.95
Dietary oligofructose lessens hepatic steatosis, but does not prevent hypertriglyceridemia in obese zucker rats. J Nutr (2000) 0.94
Current knowledge on the antagonists and inverse agonists of cannabinoid receptors. Curr Med Chem (2005) 0.94
Hereditary breast cancer in 19 females and 2 males: Kindred, P.G. 1940. Eur J Cancer (1995) 0.94
Increased glucose sensitivity of both triggering and amplifying pathways of insulin secretion in rat islets cultured for 1 wk in high glucose. Am J Physiol Endocrinol Metab (2004) 0.93
Bacteria and chocolate: a successful combination for probiotic delivery. Int J Food Microbiol (2010) 0.92
The effect of the palmitoylethanolamide analogue, palmitoylallylamide (L-29) on pain behaviour in rodent models of neuropathy. Br J Pharmacol (2007) 0.92
Hepatic steatosis in n-3 fatty acid depleted mice: focus on metabolic alterations related to tissue fatty acid composition. BMC Physiol (2008) 0.91
C-Terminal gp40 peptide analogs inhibit feline immunodeficiency virus: cell fusion and virus spread. J Virol (2002) 0.91
Gut microbiota-derived propionate reduces cancer cell proliferation in the liver. Br J Cancer (2012) 0.91
Detection of small across-channel timing differences by cochlear implantees. Hear Res (2000) 0.89
Human parainfluenza virus 3: purification and characterization of subviral components, viral proteins and viral RNA. Virus Res (1985) 0.89
Stability and activity of an Enterobacter aerogenes-specific bacteriophage under simulated gastro-intestinal conditions. Appl Microbiol Biotechnol (2004) 0.89
Arabinoxylan-oligosaccharides (AXOS) affect the protein/carbohydrate fermentation balance and microbial population dynamics of the Simulator of Human Intestinal Microbial Ecosystem. Microb Biotechnol (2008) 0.89
Oligofructose modulates lipid metabolism alterations induced by a fat-rich diet in rats. J Appl Toxicol (1998) 0.88
The use of propranolol in the treatment of hypertension. Practitioner (1973) 0.87
A review on the monoacylglycerol lipase: at the interface between fat and endocannabinoid signalling. Curr Med Chem (2010) 0.87
Human type 2 diabetes: morphological evidence for abnormal beta-cell function. Diabetes (2001) 0.87
Effect of propranolol on mortality in patients with angina. Postgrad Med J (1976) 0.86
Molecular cloning and sequence analysis of the human parainfluenza 3 virus gene encoding the matrix protein. Virology (1987) 0.86
Mutational bias in penguin microsatellite DNA. J Hered (2005) 0.86
Microbiota and their role in the pathogenesis of oral mucositis. Oral Dis (2014) 0.85
Antiretroviral activities of protease inhibitors against murine leukemia virus and simian immunodeficiency virus in tissue culture. Antimicrob Agents Chemother (1993) 0.84
Expression of prostate-specific membrane antigen in transitional cell carcinoma of the bladder: prognostic value? Clin Cancer Res (2000) 0.84
Involvement of the gut microbiota in the development of low grade inflammation associated with obesity: focus on this neglected partner. Acta Gastroenterol Belg (2010) 0.84
A simple method for increased recovery of purified paramyxovirus virions. J Virol Methods (1985) 0.84
Ethylene vinyl acetate as matrix for oral sustained release dosage forms produced via hot-melt extrusion. Eur J Pharm Biopharm (2010) 0.84
Volunteer blood donors for a cell pheresis programme. N Z Med J (1985) 0.83
Hypervitaminosis A-induced liver fibrosis: stellate cell activation and daily dose consumption. Liver Int (2006) 0.83
Harnessing the beneficial properties of adipogenic microbes for improving human health. Obes Rev (2013) 0.83
Molecular sexing of individual kakapo, Strigops habroptilus Aves, from feces. Mol Ecol (1999) 0.82
A repeat complex in the mitochondrial control region of Adélie penguins from Antarctica. Genome (2000) 0.82
Plant polyphenolics as anti-invasive cancer agents. Anticancer Agents Med Chem (2008) 0.82
Ancient DNA recovers the origins of Māori feather cloaks. Mol Biol Evol (2011) 0.82
A study of the response of herpesvirus-infected HEp-2 cells to iron uptake and ferritin biosynthesis. Lab Invest (1973) 0.82
In vitro modulation of the human gastrointestinal microbial community by plant-derived polysaccharide-rich dietary supplements. Int J Food Microbiol (2010) 0.82
Intestinal bacteria metabolize the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine following consumption of a single cooked chicken meal in humans. Food Chem Toxicol (2007) 0.81
Risk factors for feline hyperthyroidism in the UK. J Small Anim Pract (2009) 0.81
Bioavailability of phenolics from an oleuropein-rich olive (Olea europaea) leaf extract and its acute effect on plasma antioxidant status: comparison between pre- and postmenopausal women. Eur J Nutr (2013) 0.80
Gut microbial metabolism of polyphenols from black tea and red wine/grape juice is source-specific and colon-region dependent. J Agric Food Chem (2012) 0.79
Improvement of respiratory syncytial virus replication in actively growing HEp-2 cells. J Virol Methods (1983) 0.79
Mitochondrial phylogeny of trematomid fishes (Nototheniidae, Perciformes) and the evolution of Antarctic fish. Mol Phylogenet Evol (1996) 0.79
Receptor-independent effects of natural cannabinoids in rat peritoneal mast cells in vitro. Biochim Biophys Acta (2001) 0.79
Molecular ecology and biological control: the mating system of a marsupial pest. Mol Ecol (2000) 0.79
A MBP-FAAH fusion protein as a tool to produce human and rat fatty acid amide hydrolase: expression and pharmacological comparison. Amino Acids (2007) 0.78
N-(benzyloxycarbonyl)glycine esters and amides as new anticonvulsants. J Med Chem (1998) 0.78
Characterization of vaccinia virus DNA replication in vitro. Virology (1977) 0.78
Selected nondigestible carbohydrates and prebiotics support the growth of probiotic fish bacteria mono-cultures in vitro. J Appl Microbiol (2009) 0.78
Antioxidants N-acetyl-L-cysteine and manganese(III)tetrakis (4-benzoic acid)porphyrin do not prevent beta-cell dysfunction in rat islets cultured in high glucose for 1 wk. Am J Physiol Endocrinol Metab (2006) 0.78
Tolbutamide stimulation of pancreatic beta-cells involves both cell recruitment and increase in the individual Ca(2+) response. Br J Pharmacol (2001) 0.78